Blue Wave Water Capital Ltd engages in the multiplication, cultivation, production, and sale of cannabis for medical purposes. It provides cannabis to treat patients with depression and Alzheimer's. The company produces tons of processed cannabis. It operates in Israel, Australia, Asia, Europe, the United States, and Canada. It also produces and distributes hemp based cosmetic and seed oil products. The company was formerly known as Pharmocann Global Ltd and changed its name to Blue Wave Water Capital Ltd in February 2025. The company was incorporated in 1997 and is headquartered in Kiryat Tivon, Israel.
Metrics to compare | BLWV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBLWVPeersSector | |
---|---|---|---|---|
P/E Ratio | −3.9x | −0.5x | −0.5x | |
PEG Ratio | −0.05 | 0.00 | 0.00 | |
Price/Book | −37.7x | 1.0x | 2.6x | |
Price / LTM Sales | - | 0.6x | 3.2x | |
Upside (Analyst Target) | - | 123.2% | 42.7% | |
Fair Value Upside | Unlock | 11.9% | 5.8% | Unlock |